TD Waterhouse Canada’s Atossa Therapeutics ATOS Stock Holding History

TD Waterhouse Canada’s Portfolio ATOS Stock Details ATOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$210	Hold	103	–	–	﹤0.01%	2291
2026 Q1	$525	Sell	103 -1	-1%	-$6	﹤0.01%	2146
2025 Q4	$910	Hold	104	–	–	﹤0.01%	1886
2025 Q3	$1.41K	Hold	104	–	–	﹤0.01%	1869
2025 Q2	$1.28K	Hold	104	–	–	﹤0.01%	1783
2025 Q1	$1.01K	Hold	104	–	–	﹤0.01%	1742
2024 Q4	$1.46K	Hold	104	–	–	﹤0.01%	1747
2024 Q3	$2.27K	Buy	104 +61	+142%	+$1.23K	﹤0.01%	1618
2024 Q2	$774	Sell	43 -4	-9%	-$88	﹤0.01%	1743
2024 Q1	$1.28K	Hold	47	–	–	﹤0.01%	1718
2023 Q4	$637	Hold	47	–	–	﹤0.01%	1587
2023 Q3	$490	Hold	47	–	–	﹤0.01%	1595
2023 Q2	$875	Hold	47	–	–	﹤0.01%	1610
2023 Q1	$524	Hold	47	–	–	﹤0.01%	1644
2022 Q4	$407	Hold	47	–	–	﹤0.01%	1624
2022 Q3	$574	Hold	47	–	–	﹤0.01%	1614
2022 Q2	$707	Hold	47	–	–	﹤0.01%	1646
2022 Q1	$868	Hold	47	–	–	﹤0.01%	1681
2021 Q4	$1.2K	Buy	+47	New	+$1.72K	﹤0.01%	1640

Other funds holding ATOS

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

TD Waterhouse Canada's ATOS Position: Q2 2026 in Review

TD Waterhouse Canada held its Atossa Therapeutics (ATOS) position steady in Q2 2026 at 103 shares worth $210. The position accounts for ﹤0.01% of the portfolio, ranked #2291.

TD Waterhouse Canada first reported a position in ATOS in Q4 2021 and has held it in 19 quarters since. The position peaked at $2.27K in Q3 2024. 31 funds tracked by Wall St. Rank hold ATOS as of Q2 2026.

TD Waterhouse Canada held 103 shares of Atossa Therapeutics worth $210 as of Q2 2026.
TD Waterhouse Canada left its Atossa Therapeutics share count unchanged in Q2 2026.
Atossa Therapeutics made up ﹤0.01% of TD Waterhouse Canada's portfolio in Q2 2026, its #2291 holding.
TD Waterhouse Canada first reported a position in Atossa Therapeutics in Q4 2021 and has held it in 19 quarters since.
TD Waterhouse Canada's Atossa Therapeutics position peaked at $2.27K in Q3 2024.
31 funds tracked by Wall St. Rank held Atossa Therapeutics as of Q2 2026.

Based on TD Waterhouse Canada's 13F filing for Q2 2026, filed 27 Jul 2026.